Matinas BioPharma Holdings (MTNB) Change in Receivables (2015 - 2017)
Matinas BioPharma Holdings' Change in Receivables was -$5.00 in Q3 2017.
Analysis
Matinas BioPharma Holdings (MTNB) Change in Receivables (2015 - 2017) Analysis & Trends
- The Q3 2017 figure marks the lowest quarterly Change in Receivables since Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.48 Bn | 1,106.07 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 618.81 Bn | 537.34 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.67 Bn | 192.07 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 191.16 Bn | 165.36 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 169.69 Bn | 116.34 Bn | 10.94 Bn | - |
| 10 | Matinas BioPharma Holdings | 679,055.62 | -11.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | -5.00 |
| Jun 30, 2015 | 29,748.00 |
| Mar 31, 2015 | -15,535.00 |
API Access
Matinas BioPharma Holdings Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=MTNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();